Emerging in the field of weight management management, retatrutide is a different strategy. Unlike many available medications, retatrutide works as a twin agonist, at once targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. The dual engagement fosters several helpful effects, like improve